Michael Coussa-Charley

Gut microbiota: next frontier in understanding human health and development of biotherapeutics

Satya Prakash, Laetitia Rodes, Michael Coussa-Charley et al. · Biologics · 2011 · 254 citations · Full text

Dysbiosis, Host-microbe Interactions, Gut Microbiota +20

Probiotic Ferulic Acid Esterase Active Lactobacillus fermentum NCIMB 5221 APA Microcapsules for Oral Delivery: Preparation and in Vitro Characterization

Catherine Tomaro-Duchesneau, Shyamali Saha, Meenakshi Malhotra et al. · Pharmaceuticals · 2012 · 60 citations · Full text

Vitro Characterization, Probiotic, Engineering +13

Lactobacillus fermentum NCIMB 5221 has a greater ferulic acid production compared to other ferulic acid esterase producing Lactobacilli

Catherine Tomaro-Duchesneau, Sanjib Saha, Meenakshi Malhotra et al. · eSpace (Curtin University) · 2012 · 31 citations · Full text

Bacteriology, Microbial Physiology, Free Fa +20

Transit Time Affects the Community Stability of<i>Lactobacillus</i>and<i>Bifidobacterium</i>Species in an<i>In Vitro</i>Model of Human Colonic Microbiotia

Laetitia Rodes, Arghya Paul, Michael Coussa-Charley et al. · Artificial Cells Blood Substitutes and Biotechnology · 2011 · 24 citations

Use of Artificial Cell Microcapsule Containing Thalidomide for Treating TNBS-induced Crohn's Disease in Mice

Marc Fakhoury, Michael Coussa-Charley, Hani Al‐Salami et al. · Current Drug Delivery · 2014 · 21 citations